Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology
Go back to Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology| (NASDAQ: ELTX) | Delayed: 2.80 -0.5 (15.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.30 | 52 Week High | $ | |||
| Open | $3.30 | 52 Week Low | $ | |||
| Day High | $3.32 | P/E | N/A | |||
| Day Low | $2.77 | EPS | $ | |||
| Volume | 1,407,099 | |||||

